Innovative Tools for Digital Pathology: Automated ROI Detection and Image Patch Extraction
Read more
ARIA
Our data harmonization and secure sharing platform. Enabling ‘data generators’ to securely share, and ‘data consumers’ to securely access, curated clinical ‘omic data.
In the era of data-driven medicine, ARIA offers researchers a centralized, modular solution designed to manage the complexities of multi-omic data analysis. With semi-automated & tool assisted data ingress, harmonization, and assembly, ARIA provides the flexibility and scalability needed to uncover transformative insights, whether you're conducting population-scale studies or focused investigations.
For data generators: Diagnostic labs, patient registries and other generators of clinical ‘omic can use ARIA to easily ingest, assemble and share data either for internal strategic insight or operational purposes, or externally to drive new revenue streams
For data consumers: Biotech, pharma, academia and government agencies can benefit from accessing novel data sources of pre-assembled data, allowing them to spend their time on deriving insight and not on pre-processing data for analysis.
Why use ARIA
For data generators – Simple, secure sharing
ARIA ensures that data generators are able to share their data safely and securely with minimum effort:
For data consumers - rapid insights
ARIA ensures that data consumers can access data quickly, minimizing time spent on preparing or analyzing data and maximizing time spent on deriving insights
Who we help accelerate
Data generators: Clinical Diagnostic Laboratories
With Velsera’s help, diagnostic labs are uncovering opportunities embedded within the data they already collect. By harmonizing scattered, siloed, and unstructured clinical-genomic information, the newly assembled data can then either be directly commercialized, or can enable analysis and insights that help inform strategic and operational decision-making within your lab.
Data generators & data consumers : Non-profits & government agencies
With Velsera’s help, government agencies and non-profits are uncovering opportunities embedded within the data they already collect. By harmonizing scattered, siloed, and unstructured clinical-genomic information, we are help assemble data and make this available to Researchers for novel discovery work. Learn how we can help you increase the scale of your research or unlock new revenue streams through commercializing data.
Data consumers: Biotech & Pharma
Learn how we can help you access new data sources to advance your research priorities. Velsera understands that data is valuable, but discoveries are the end-goal. Using our data harmonization teams and tools you can spend all your time on insights and reduce the need for preparing and pre-processing data, while our expert bioinformaticians and technology teams can modify our solutions to do exactly what you need, reducing your time spent on mundane or low value-add tasks.
Solutions
Clinical & 'omic data unlock
With Velsera’s help, diagnostic labs are uncovering opportunities embedded within the data they already collect. By harmonizing scattered, siloed, and unstructured clinical-genomic information, we are helping labs assemble data and make this available to Biotech and Pharma for novel discovery work. Learn how we can help you access new data sources to advance your research priorities.
Real-world impact, trusted partnerships
“We are in a race against time to find better therapies so that all patients with pancreatic cancer have the opportunity to thrive, and we are confident that large-scale, multi-omics projects will provide us the data that will speed progress. Our research platform features a custom interface that was purpose-built to the needs of our researchers and supports our rich data models and data integrations. This interface was built on top of ARIA, and we are grateful for the exploration and search capabilities it provides for users.”
Blog
On December 12, 2024 | By Jovan Babic
Read more
Blog
On October 29, 2024 | By Christopher Wilkinson
Read more
Blog
On October 10, 2024 | By Cates Mallaney
Read more
News
On October 8, 2024 | By The Velsera Clinical and Compliance Team
Read more